As stated earlier this special program is a trial program which means it is only open to some selected persons and there are specific outcomes being monitored. About 400 people have been chosen to take part in the trial program. These persons will be given access to procure recreational cannabis products from designated pharmacies. The cannabis products to be used in this program will be produced by Pure Production which is based in Switzerland.